Showing results (1-10 of 152) with videos related to
Sort By:
Pageof 16
Advances in Neurobiology|March 17, 2023
Reverse Engineering Drugs: Lorcaserin as an ExampleTiffany Schwasinger-Schmidt, Sheldon H PreskornAdvances in Neurobiology|March 17, 2023
Discovery of New Transmitter Systems and Hence New Drug TargetsTiffany Schwasinger-Schmidt, Sheldon H PreskornJournal of Psychiatric Practice|May 24, 2012
Clinically important differences in the pharmacokinetics of the ten newer "atypical" antipsychotics: part 1Sheldon H PreskornJournal of Psychiatric Practice|March 3, 2022
How Loading Dose Strategies for Depot Paliperidone Can Go WrongSheldon H PreskornJournal of Psychiatric Practice|September 7, 2023
Eight Clinical Cases and the Lessons They TaughtSheldon H PreskornJournal of Psychiatric Practice|January 6, 2022
An Individual With 2 Distinct Nonpathologic IdentitiesSheldon H PreskornJournal of Psychiatric Practice|January 11, 2017
Use of an Analog Scale in the Treatment of Patients With Bipolar Disorder to Optimize Assessment and Clinical OutcomeSheldon H PreskornJournal of Psychiatric Practice|July 7, 2022
Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug DevelopmentSheldon H PreskornJournal of Psychiatric Practice|November 19, 2014
CNS drug development: lessons from the development of ondansetron, aprepitant, ramelteon, varenicline, lorcaserin, and suvorexant. Part ISheldon H PreskornHandbook of Experimental Pharmacology|December 21, 2018
Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational DevelopmentSheldon H PreskornPageof 16